Literature DB >> 34052415

Human meibum and tear film derived (O-acyl)-omega-hydroxy fatty acids in meibomian gland dysfunction.

Safal Khanal1, William Ngo2, Kelly K Nichols1, Landon Wilson3, Stephen Barnes3, Jason J Nichols4.   

Abstract

PURPOSE: The molecular basis of the tear film and lipid layer alterations in meibomian gland dysfunction (MGD) is unknown. This study aimed to identify and compare (O-acyl)-omega-hydroxy fatty acids (OAHFAs) derived from human meibum and tears in MGD.
METHODS: Of 195 eligible subjects (18-84 years, 62.6% female), 183 and 174 provided samples for tears and meibum, respectively. Subjects were classified into four groups: Normal, Asymptomatic MGD, MGD, and Mixed. Samples from the right eye of each subject were infused into the SCIEX 5600 TripleTOF mass spectrometer in negative ion mode. Lipid intensities identified with Analyst1.7 TF and SCIEX LipidView1.3 were normalized by an internal standard and total ion current, then statistically compared in MetaboAnalyst 4.0.
RESULTS: In meibum and tears, 76 and 78 unique OAHFAs were identified, respectively. The five most frequent and abundant OAHFAs were 18:2/16:2, 18:1/32:1, 18:1/30:1, 18:2/32:1, and 18:1/34:1. Two OAHFAs, 18:2/20:2 and 18:2/20:1, were identified only in tears. Initial univariate analysis revealed three differently regulated OAHFAs in meibum and eight in tears. Partial Least Square Discriminant Analysis showed 18:1/32:1, 18:2/16:2, 18:1/34:1 and 18:0/32:1 in tears, and 18:2/16:2, 18:1/32:1 and 18:2/32:2 in meibum, had variable importance in projection scores >1.5 and contributed the most to the separation of groups. In both meibum and tears, all OAHFAS except 18:2/16:2 were reduced in MGD compared to the normal group.
CONCLUSION: MGD is accompanied by differential expression of specific OAHFAs in meibum and tears. These results suggest OAHFAs play a role in the altered biochemical profile of the tear film lipid layer in humans with MGD.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (o-acyl)-omega-hydroxy fatty acids; Lipids; Meibomian glands; Meibum; Tear film; dry eye disease

Mesh:

Substances:

Year:  2021        PMID: 34052415      PMCID: PMC8328926          DOI: 10.1016/j.jtos.2021.05.009

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   6.268


  60 in total

Review 1.  Untargeted lipidomic analysis of human tears: A new approach for quantification of O-acyl-omega hydroxy fatty acids.

Authors:  Jianzhong Chen; Kelly K Nichols; Landon Wilson; Stephen Barnes; Jason J Nichols
Journal:  Ocul Surf       Date:  2019-02-25       Impact factor: 5.033

2.  Reliability and validity of the Ocular Surface Disease Index.

Authors:  R M Schiffman; M D Christianson; G Jacobsen; J D Hirsch; B L Reis
Journal:  Arch Ophthalmol       Date:  2000-05

3.  Application of a novel interferometric method to investigate the relation between lipid layer thickness and tear film thinning.

Authors:  P Ewen King-Smith; Erich A Hinel; Jason J Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

4.  Mass spectrometry-directed structure elucidation and total synthesis of ultra-long chain (O-acyl)-ω-hydroxy fatty acids.

Authors:  Sarah E Hancock; Ramesh Ailuri; David L Marshall; Simon H J Brown; Jennifer T Saville; Venkateswara R Narreddula; Nathan R Boase; Berwyck L J Poad; Adam J Trevitt; Mark D P Willcox; Michael J Kelso; Todd W Mitchell; Stephen J Blanksby
Journal:  J Lipid Res       Date:  2018-06-15       Impact factor: 5.922

5.  Polar lipids in human meibomian gland secretions.

Authors:  Ward E Shine; James P McCulley
Journal:  Curr Eye Res       Date:  2003-02       Impact factor: 2.424

6.  Rapid identification of fatty acids and (O-acyl)-ω-hydroxy fatty acids in human meibum by liquid chromatography/high-resolution mass spectrometry.

Authors:  Naoto Mori; Yasufumi Fukano; Reiko Arita; Rika Shirakawa; Kouichi Kawazu; Masatsugu Nakamura; Shiro Amano
Journal:  J Chromatogr A       Date:  2014-05-01       Impact factor: 4.759

7.  Human tear fluid lipidome: from composition to function.

Authors:  Antti H Rantamäki; Tuulikki Seppänen-Laakso; Matej Oresic; Matti Jauhiainen; Juha M Holopainen
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

8.  Pre-corneal tear film thickness in humans measured with a novel technique.

Authors:  Kaveh Azartash; Justin Kwan; Jerry R Paugh; Andrew Loc Nguyen; James V Jester; Enrico Gratton
Journal:  Mol Vis       Date:  2011-03-22       Impact factor: 2.367

9.  Meibum lipid composition in Asians with dry eye disease.

Authors:  Sin Man Lam; Louis Tong; Siew Sian Yong; Bowen Li; Shyam S Chaurasia; Guanghou Shui; Markus R Wenk
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

10.  Lipid polarity gradient formed by ω-hydroxy lipids in tear film prevents dry eye disease.

Authors:  Masatoshi Miyamoto; Takayuki Sassa; Megumi Sawai; Akio Kihara
Journal:  Elife       Date:  2020-04-07       Impact factor: 8.140

View more
  4 in total

1.  Characterization of the thickness of the Tear Film Lipid Layer in Meibomian Gland Dysfunction using high resolution optical microscopy.

Authors:  Yuqiang Bai; William Ngo; Safal Khanal; Jason J Nichols
Journal:  Ocul Surf       Date:  2021-12-27       Impact factor: 6.268

2.  Meibum sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids.

Authors:  Anat Galor; Victor Sanchez; Andrew Jensen; Madeline Burton; Kenneth Maus; Daniel Stephenson; Charles Chalfant; Nawajes Mandal
Journal:  Ocul Surf       Date:  2021-11-30       Impact factor: 6.268

Review 3.  Candidate Molecular Compounds as Potential Indicators for Meibomian Gland Dysfunction.

Authors:  Kofi Asiedu
Journal:  Front Med (Lausanne)       Date:  2022-05-24

4.  Lipidomics Profiles Revealed Alterations in Patients With Meibomian Gland Dysfunction After Exposure to Intense Pulsed Light.

Authors:  Hui Zhao; Shi-Nan Wu; Yi Shao; Dong Xiao; Li-Ying Tang; Zhe Cheng; Jie Peng
Journal:  Front Neurol       Date:  2022-02-15       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.